• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to (2-Isopropylpyrimidin-4-yl)methylmethylamine dihydrochloride (CAS No. 921074-88-6)

(2-Isopropylpyrimidin-4-yl)methylmethylamine dihydrochloride, identified by its CAS number 921074-88-6, is a significant compound in the realm of pharmaceutical research and development. This compound belongs to the pyrimidine derivative class, which has garnered considerable attention due to its diverse biological activities and potential therapeutic applications.

The molecular structure of (2-Isopropylpyrimidin-4-yl)methylmethylamine dihydrochloride incorporates a pyrimidine core substituted with an isopropyl group at the 2-position and a methylamine moiety at the 4-position. The dihydrochloride salt form enhances its solubility in aqueous solutions, making it more amenable for various biochemical and pharmacological studies.

In recent years, pyrimidine derivatives have been extensively studied for their roles in modulating various biological pathways. The presence of the isopropyl group in the pyrimidine ring contributes to the compound's unique electronic and steric properties, which can influence its interactions with biological targets. This structural feature has made (2-Isopropylpyrimidin-4-yl)methylmethylamine dihydrochloride a promising candidate for further investigation in drug discovery.

One of the most compelling aspects of this compound is its potential as an intermediate in the synthesis of more complex pharmacophores. Researchers have leveraged its structural framework to develop novel molecules with enhanced binding affinity and selectivity towards specific biological receptors. For instance, studies have indicated that derivatives of this compound may exhibit inhibitory effects on certain enzymes implicated in inflammatory responses and cancer progression.

The pharmacological profile of ((2-Isopropylpyrimidin-4-yl)methylmethylamine) dihydrochloride has been explored in several preclinical studies. These investigations have highlighted its ability to interact with a variety of molecular targets, including kinases and transcription factors. The compound's dual functionality, arising from the combination of the pyrimidine core and the methylamine group, allows for versatile chemical modifications that can fine-tune its biological activity.

Recent advancements in computational chemistry have enabled more accurate predictions of the binding interactions between ((2-Isopropylpyrimidin-4-yl)methylmethylamine) dihydrochloride and its target proteins. Molecular docking studies have suggested that this compound may bind to pockets on enzymes such as Janus kinases (JAKs) and signal transducer and activator of transcription (STAT) proteins, which are crucial regulators of immune responses and cell growth.

The synthesis of ((2-Isopropylpyrimidin-4-yl)methylmethylamine) dihydrochloride involves multi-step organic reactions, starting from commercially available precursors. The key steps include condensation reactions to form the pyrimidine ring, followed by functional group transformations to introduce the isopropyl and methylamine substituents. The final step involves salt formation with hydrochloric acid to enhance solubility and stability.

In conclusion, ((2-Isopropylpyrimidin-4-yl)methylmethylamine) dihydrochloride (CAS No. 921074-88-6) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features and demonstrated biological activities make it a valuable tool for developing novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development efforts worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)